Paclitaxel, carboplatin plus gemcitabine (PCG) as first-line treatment for advanced epithelial ovarian cancer (EOC): Pathologic complete response (pCR) and impact on cognitive functioning Meeting Abstract
| Authors: | Hensley, M. L.; Correa, D.; Thaler, H.; Wilton, A.; Venkatraman, E.; Sabbatini, P.; Chi, D.; Spriggs, D.; Aghajanian, C. |
| Abstract Title: | Paclitaxel, carboplatin plus gemcitabine (PCG) as first-line treatment for advanced epithelial ovarian cancer (EOC): Pathologic complete response (pCR) and impact on cognitive functioning |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 459S |
| Language: | English |
| ACCESSION: | WOS:000230326603061 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.5016 |
| Notes: | --- - Meeting Abstract: 5016 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
